Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Department of Biomedical Engineering, The University of Memphis, Memphis, Tennessee, USA.
J Magn Reson Imaging. 2021 Sep;54(3):721-727. doi: 10.1002/jmri.27584. Epub 2021 Feb 26.
R2*-MRI is clinically used to noninvasively assess hepatic iron content (HIC) to guide potential iron chelation therapy. However, coexisting pathologies, such as fibrosis and steatosis, affect R2* measurements and may thus confound HIC estimations.
To evaluate whether a multispectral auto regressive moving average (ARMA) model can be used in conjunction with quantitative susceptibility mapping (QSM) to measure magnetic susceptibility as a confounder-free predictor of HIC.
Phantom study and in vivo cohort.
Nine iron phantoms covering clinically relevant R2* range (20-1200/second) and 48 patients (22 male, 26 female, median age 18 years).
FIELD STRENGTH/SEQUENCE: Three-dimensional (3D) and two-dimensional (2D) multi-echo gradient echo (GRE) at 1.5 T.
ARMA-QSM modeling was performed on the complex 3D GRE signal to estimate R2*, fat fraction (FF), and susceptibility measurements. R2*-based dry clinical HIC values were calculated from the 2D GRE acquisition using a published R2*-HIC calibration curve as reference standard.
Linear regression analysis was performed to compare ARMA R2* and susceptibility-based estimates to iron concentrations and dry clinical HIC values in phantoms and patients, respectively.
In phantoms, the ARMA R2* and susceptibility values strongly correlated with iron concentrations (R ≥ 0.9). In patients, the ARMA R2* values highly correlated (R = 0.97) with clinical HIC values with slope = 0.026, and the susceptibility values showed good correlation (R = 0.82) with clinical dry HIC values with slope = 3.3 and produced a dry-to-wet HIC ratio of 4.8.
This study shows the feasibility that ARMA-QSM can simultaneously estimate susceptibility-based wet HIC, R2*-based dry HIC and FFs from a single multi-echo GRE acquisition. Our results demonstrate that both, R2* and susceptibility-based wet HIC values estimated with ARMA-QSM showed good association with clinical dry HIC values with slopes similar to published R2*-biopsy HIC calibration and dry-to-wet tissue weight ratio, respectively. Hence, our study shows that ARMA-QSM can provide potentially confounder-free assessment of hepatic iron overload.
3 TECHNICAL EFFICACY: Stage 2.
R2*-MRI 临床上用于非侵入性地评估肝铁含量(HIC),以指导潜在的铁螯合治疗。然而,共存的病理学,如纤维化和脂肪变性,会影响 R2*的测量,从而可能干扰 HIC 的估计。
评估多谱自动回归移动平均(ARMA)模型是否可与定量磁化率映射(QSM)结合使用,以测量磁化率作为无混杂因素的 HIC 预测因子。
体模研究和体内队列研究。
9 个涵盖临床相关 R2*范围(20-1200/秒)的铁体模和 48 名患者(22 名男性,26 名女性,中位年龄 18 岁)。
磁场强度/序列:1.5T 下的三维(3D)和二维(2D)多回波梯度回波(GRE)。
对复杂的 3D GRE 信号进行 ARMA-QSM 建模,以估计 R2*、脂肪分数(FF)和磁化率测量值。使用已发表的 R2*-HIC 校准曲线作为参考标准,从 2D GRE 采集计算基于 R2*的干临床 HIC 值。
对体模和患者的 ARMA R2*和基于磁化率的估计值与铁浓度和干临床 HIC 值进行线性回归分析。
在体模中,ARMA R2和磁化率值与铁浓度强烈相关(R ≥ 0.9)。在患者中,ARMA R2值与临床 HIC 值高度相关(R = 0.97),斜率为 0.026,磁化率值与临床干 HIC 值具有良好的相关性(R = 0.82),斜率为 3.3,并产生 4.8 的干湿 HIC 比值。
本研究表明,ARMA-QSM 可从单次多回波 GRE 采集同时估计基于磁化率的湿 HIC、基于 R2的干 HIC 和 FF,这是可行的。我们的结果表明,基于 ARMA-QSM 估计的 R2和基于磁化率的湿 HIC 值与临床干 HIC 值具有良好的相关性,斜率与已发表的 R2*-活检 HIC 校准和干-湿组织重量比相似。因此,本研究表明 ARMA-QSM 可以提供潜在无混杂因素的肝铁过载评估。
3 级 技术功效:第 2 阶段。